Researchers have defined a new genetic disease caused by a mutation in the IVNS1ABP gene. The condition marks a rare ...
Researchers reported at the 2026 European Lung Cancer Congress that Hernexeos (zongertinib) led to high response rates and ...
Nuvation Bio Inc., a global oncology company focused on tackling some of the toughest challenges in cancer treatment, announced the company has amended its existing exclusive license agreement for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results